Acute Preoperative Infarcts and Poor Cerebrovascular Reserve Are Independent Risk Factors for Severe Ischemic Complications following Direct Extracranial-Intracranial Bypass for Moyamoya Disease

References

1. 1.↵
   2. Ma Y,
   3. Meng L,
   4. Jiao LQ, et al

   . Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with Moyamoya disease. Neurosurg Rev 2011;34:347–54 doi:10.1007/s10143-011-0312-y pmid:21538064

   CrossRefPubMed
2. 2.↵
   2. Ikezaki K

   . Rational approach to treatment of Moyamoya disease in childhood. J Child Neurol 2000;15:350–56 doi:10.1177/088307380001500512 pmid:10830202

   Abstract/FREE Full Text
3. 3.↵
   2. Togao O,
   3. Mihara F,
   4. Yoshiura T, et al

   . Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR Am J Neuroradiol 2006;27:391–97 pmid:16484417

   Abstract/FREE Full Text
4. 4.↵
   2. Suzuki J,
   3. Takaku A

   . Cerebrovascular “Moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99 doi:10.1001/archneur.1969.00480090076012 pmid:5775283

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Yun TJ,
   3. Cheon JE,
   4. Na DG, et al

   . Childhood Moyamoya disease: quantitative evaluation of perfusion MR imaging—correlation with clinical outcome after revascularization surgery. Radiology 2009;251:216–23 doi:10.1148/radiol.2511080654 pmid:19332853

   CrossRefPubMed
6. 6.↵
   2. Pandey P,
   3. Steinberg GK

   . Neurosurgical advances in the treatment of Moyamoya disease. Stroke 2011;42:3304–10 doi:10.1161/STROKEAHA.110.598565 pmid:21980214

   Abstract/FREE Full Text
7. 7.↵
   2. Karasawa J,
   3. Kikuchi H,
   4. Furuse S, et al

   . Treatment of Moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978;49:679–88 doi:10.3171/jns.1978.49.5.0679 pmid:712390

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Guzman R,
   3. Lee M,
   4. Achrol A, et al

   . Clinical outcome after 450 revascularization procedures for Moyamoya disease: clinical article. J Neurosurg 2009;111:927–35 doi:10.3171/2009.4.JNS081649 pmid:19463046

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Lee M,
   3. Guzman R,
   4. Bell-Stephens T, et al

   . Intraoperative blood flow analysis of direct revascularization procedures in patients with Moyamoya disease. J Cereb Blood Flow Metab 2011;31:262–74 doi:10.1038/jcbfm.2010.85 pmid:20588321

   Abstract/FREE Full Text
10. 10.↵
    2. Powers WJ,
    3. Clarke WR,
    4. Grubb RL Jr., et al

    ; COSS Investigators. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA 2011;306:1983–92 doi:10.1001/jama.2011.1610 pmid:22068990

    CrossRefPubMedWeb of Science
11. 11.↵
    EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med 1985;313:1191–200 doi:10.1056/NEJM198511073131904 pmid:2865674

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Straka M,
    3. Albers GW,
    4. Bammer R

    . Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010;32:1024–37 doi:10.1002/jmri.22338 pmid:21031505

    CrossRefPubMed
13. 13.↵
    2. Qiu D,
    3. Straka M,
    4. Zun Z, et al

    . CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging 2012;36:110–19 doi:10.1002/jmri.23613 pmid:22359345

    CrossRefPubMed
14. 14.↵
    2. Zaharchuk G,
    3. Bammer R,
    4. Straka M, et al

    . Improving dynamic susceptibility contrast MRI measurement of quantitative cerebral blood flow using corrections for partial volume and nonlinear contrast relaxivity: a xenon computed tomographic comparative study. J Magn Reson Imaging 2009;30:743–52 doi:10.1002/jmri.21908 pmid:19787719

    CrossRefPubMed
15. 15.↵
    2. Settakis G,
    3. Molnar C,
    4. Kerenyi L, et al

    . Acetazolamide as a vasodilatory stimulus in cerebrovascular disease and in conditions affecting the cerebral vasculature. Eur J Neurol 2003;10:609–20 doi:10.1046/j.1468-1331.2003.00675.x pmid:14641504

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Chang SD,
    3. Steinberg GK

    . Surgical management of Moyamoya disease. Moyamoya.com. http://www.moyamoya.com/journals/moyamoya.html. . Last update January 1, 2013Accessed April 1, 2015.
17. 17.↵
    1. Abdulrauf SI

    2. Li G,
    3. Lim M,
    4. Khan N, et al

    . Cerebral revascularization for Moyamoya disease. In: Abdulrauf SI, ed. Cerebral Revascularization: Techniques in Extracranial-to-Intracranial Bypass Surgery. Philadelphia: Elsevier; 2011:185–92
18. 18.↵
    2. Guzman R,
    3. Steinberg GK

    . Direct bypass technique for the treatment of pediatric Moyamoya disease. Neurosurg Clin N Am 2010;21:565–73 doi:10.1016/j.nec.2010.03.013 pmid:20561504

    CrossRefPubMed
19. 19.↵
    JET Study Group. Japanese EC-IC bypass trial (JET study): study design and interim analysis [in Japanese]. Surg Cereb Stroke (Jpn) 2002;30:97–100 doi:10.2335/scs.30.97

    CrossRef
20. 20.↵
    2. Kuroda S,
    3. Houkin K,
    4. Kamiyama H, et al

    . Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110–16 doi:10.1161/hs0901.095692 pmid:11546904

    Abstract/FREE Full Text
21. 21.↵
    2. Grubb RL Jr.,
    3. Derdeyn CP,
    4. Fritsch SM, et al

    . Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055–60 doi:10.1001/jama.280.12.1055 pmid:9757852

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Gupta A,
    3. Chazen JL,
    4. Hartman M, et al

    . Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis. Stroke 2012;43:2884–91 doi:10.1161/STROKEAHA.112.663716 pmid:23091119

    Abstract/FREE Full Text
23. 23.↵
    2. Schoof J,
    3. Lubahn W,
    4. Baeumer M, et al

    . Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007;134:690–96 doi:10.1016/j.jtcvs.2007.03.018 pmid:17723819

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Nariai T,
    3. Suzuki R,
    4. Matsushima Y, et al

    . Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke 1994;25:1014–21 doi:10.1161/01.STR.25.5.1014 pmid:8165672

    Abstract/FREE Full Text
25. 25.↵
    2. Hyun SJ,
    3. Kim JS,
    4. Hong SC

    . Prognostic factors associated with perioperative ischemic complications in adult-onset Moyamoya disease. Acta Neurochir (Wien) 2010;152:1181–88 doi:10.1007/s00701-010-0638-1 pmid:20373117

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Ohue S,
    3. Kumon Y,
    4. Kohno K, et al

    . Postoperative temporary neurological deficits in adults with Moyamoya disease. Surg Neurol 2008;69:281–86; discussion 286–87 doi:10.1016/j.surneu.2007.01.047 pmid:17996267

    CrossRefPubMed
27. 27.↵
    2. Tanaka Y,
    3. Nariai T,
    4. Nagaoka T, et al

    . Quantitative evaluation of cerebral hemodynamics in patients with Moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging: comparison with positron emission tomography. J Cereb Blood Flow Metab 2006;26:291–300 doi:10.1038/sj.jcbfm.9600187 pmid:16049427

    Abstract/FREE Full Text